WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Badreddin EdrisDirector2026-01-217,605$0.71
$5.40kBuy
Badreddin EdrisDirector2026-01-2117,236$0.64
$11.03kBuy
Badreddin EdrisDirector2026-01-2110,463$1.93
$20.19kBuy
Badreddin EdrisDirector2026-01-2166,477$1.93
$128.30kBuy
Badreddin EdrisDirector2026-01-2110,463$29.44
$308.03kSell
Badreddin EdrisDirector2026-01-217,605$29.44
$223.89kSell
Badreddin EdrisDirector2026-01-2117,236$29.44
$507.43kSell
Badreddin EdrisDirector2026-01-2113,690$29.44
$403.03kSell
Badreddin EdrisDirector2026-01-2166,477$29.44
$1.96MSell
Badreddin EdrisDirector2026-01-2113,690$0.39
$5.34kBuy

1 of 5

EWTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.66%15,518,492$445.07MInstitution
Ra Capital Management LP9.85%10,428,437$299.09MInstitution
Baker Bros Advisors LP6.90%7,305,940$209.53MInstitution
Blackrock Inc6.00%6,351,487$182.16MInstitution
Paradigm Biocapital Advisors LP5.83%6,170,131$176.96MInstitution
Holdings A. Novo5.74%6,071,703$174.14MInsider
Novo Holdings A5.05%5,350,000$153.44MInstitution
Braidwell LP4.92%5,210,831$149.45MInstitution
Janus Henderson Group PLC4.70%4,979,331$142.81MInstitution
Vanguard Group Inc4.54%4,803,941$137.78MInstitution

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX87.72%12.28%Net BuyingNet Buying
VCYT67.83%32.17%Net SellingNet Selling
CPRX84.02%15.89%Net SellingNet Selling
TERN81.05%18.95%Net SellingNet Selling
BEAM86.38%13.62%Net SellingNet Selling
View Top Biotech Stocks

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 105.76% institutional shareholders, 14.81% Edgewise Therapeutics insiders, and 0.00% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 5.74% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $174.74M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.